Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients

Karin Melanie Cabanillas Stanchi(University Children's Hospital Tübingen), Michaela Döring(University Children's Hospital Tübingen), Rupert Handgretinger(STZ eyetrial), Christian Seitz(German Cancer Research Center), Carmen Malaval(University Children's Hospital Tübingen), Manon Queudeville(University Children's Hospital Tübingen), Markus Dobratz(University Children's Hospital Tübingen), Peter Lang(STZ eyetrial), Judith Feucht(Memorial Sloan Kettering Cancer Center), Patrick Schlegel(University of Würzburg), Ingo Müller(Universität Hamburg)
Journal of Cancer Research and Clinical Oncology
August 24, 2019
10.1007/s00432-019-03008-9
Cited by 10

Related Papers

Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,
|The Journal of Immunology|2005|1.7k
Rational Extended Thermodynamics
|Springer Tracts in Natural Philosophy|1998|1.3k
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
|Blood|2010|430
A thermodynamic theory of mixtures of fluids
|Archive for Rational Mechanics and Analysis|1968|428
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376